Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

Part of paid clinical trials in Aurora, Colorado.

Sponsor
VA Office of Research and Development
Study ID
NCT05028972
Status
Recruiting

Conditions

  • Emergency Service
  • Hearing Loss
  • Hospital Readmission

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Personal Amplifier — OTHER
    The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED
  • No Personal Amplifier — OTHER
    The control group will not receive personal amplifiers while they receive care in the ED

Study Details

HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.

Key Dates

Start date
Dec 8, 2021
Status verified
Oct 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
1,050 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention: Personal Amplifier
    Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department
  • Other: Control: No Personal Amplifier
    Consenting participants will be randomly assigned to the control group while receiving care in the emergency department

Primary Outcome Measure

ED 3-day Readmissions [ Time Frame: 3-5 days after initial ED stay ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Rocky Mountain Regional VA Medical Center, Aurora, COAuroraColorado80045-7211
Lauren Abbate, MD
303-399-8020
VA NY Harbor Healthcare System, New York, NYNew YorkNew York10010-5011
Tali Finkelstein, MPA
(212) 686-7500
Olga Dotsenko
(212) 686-7500
Joshua Chodosh, MD MSHS (PRINCIPAL_INVESTIGATOR)
Syracuse VA Medical Center, Syracuse, NYSyracuseNew York13210
Kevin Corcoran, DO
315-425-4400
James J. Peters VA Medical Center, Bronx, NYThe BronxNew York10468
Ula Hwang, MD
718-584-9000
Durham VA Medical Center, Durham, NCDurhamNorth Carolina27705-3875
Luna Ragsdale, MD
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TXDallasTexas75216
Rohit Manaktala, MD

Find similar trials in Aurora, CO

Related Studies